Please use this identifier to cite or link to this item:
https://doi.org/10.1126/scitranslmed.3007355
DC Field | Value | |
---|---|---|
dc.title | Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis | |
dc.contributor.author | Rao, S.P.S. | |
dc.contributor.author | Lakshminarayana, S.B. | |
dc.contributor.author | Kondreddi, R.R. | |
dc.contributor.author | Herve, M. | |
dc.contributor.author | Camacho, L.R. | |
dc.contributor.author | Bifani, P. | |
dc.contributor.author | Kalapala, S.K. | |
dc.contributor.author | Jiricek, J. | |
dc.contributor.author | Ma, N.L. | |
dc.contributor.author | Tan, B.H. | |
dc.contributor.author | Ng, S.H. | |
dc.contributor.author | Nanjundappa, M. | |
dc.contributor.author | Ravindran, S. | |
dc.contributor.author | Seah, P.G. | |
dc.contributor.author | Thayalan, P. | |
dc.contributor.author | Lim, S.H. | |
dc.contributor.author | Lee, B.H. | |
dc.contributor.author | Goh, A. | |
dc.contributor.author | Barnes, W.S. | |
dc.contributor.author | Chen, Z. | |
dc.contributor.author | Gagaring, K. | |
dc.contributor.author | Chatterjee, A.K. | |
dc.contributor.author | Pethe, K. | |
dc.contributor.author | Kuhen, K. | |
dc.contributor.author | Walker, J. | |
dc.contributor.author | Feng, G. | |
dc.contributor.author | Babu, S. | |
dc.contributor.author | Zhang, L. | |
dc.contributor.author | Blasco, F. | |
dc.contributor.author | Beer, D. | |
dc.contributor.author | Weaver, M. | |
dc.contributor.author | Dartois, V. | |
dc.contributor.author | Glynne, R. | |
dc.contributor.author | Dick, T. | |
dc.contributor.author | Smith, P.W. | |
dc.contributor.author | Diagana, T.T. | |
dc.contributor.author | Manjunatha, U.H. | |
dc.date.accessioned | 2016-07-08T09:27:56Z | |
dc.date.available | 2016-07-08T09:27:56Z | |
dc.date.issued | 2013-12-04 | |
dc.identifier.citation | Rao, S.P.S., Lakshminarayana, S.B., Kondreddi, R.R., Herve, M., Camacho, L.R., Bifani, P., Kalapala, S.K., Jiricek, J., Ma, N.L., Tan, B.H., Ng, S.H., Nanjundappa, M., Ravindran, S., Seah, P.G., Thayalan, P., Lim, S.H., Lee, B.H., Goh, A., Barnes, W.S., Chen, Z., Gagaring, K., Chatterjee, A.K., Pethe, K., Kuhen, K., Walker, J., Feng, G., Babu, S., Zhang, L., Blasco, F., Beer, D., Weaver, M., Dartois, V., Glynne, R., Dick, T., Smith, P.W., Diagana, T.T., Manjunatha, U.H. (2013-12-04). Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis. Science Translational Medicine 5 (214) : -. ScholarBank@NUS Repository. https://doi.org/10.1126/scitranslmed.3007355 | |
dc.identifier.issn | 19466234 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/125502 | |
dc.description.abstract | New chemotherapeutic compounds against multidrug-resistant Mycobacterium tuberculosis (Mtb) are urgently needed to combat drug resistance in tuberculosis (TB). We have identified and characterized the indolcarboxamides as a new class of antitubercular bactericidal agent. Genetic and lipid profiling studies identified the likely molecular target of indolcarboxamides as MmpL3, a transporter of trehalose monomycolate that is essential for mycobacterial cell wall biosynthesis. Two lead candidates, NITD-304 and NITD-349, showed potent activity against both drugsensitive and multidrug-resistant clinical isolates of Mtb. Promising pharmacokinetic profiles of both compounds after oral dosing in several species enabled further evaluation for efficacy and safety. NITD-304 and NITD-349 were efficacious in treating both acute and chronic Mtb infections in mouse efficacy models. Furthermore, dosing of NITD-304 and NITD-349 for 2 weeks in exploratory rat toxicology studies revealed a promising safety margin. Finally, neither compound inhibited the activity of major cytochrome P-450 enzymes or the hERG (human ether-a-go-go related gene) channel. These results suggest that NITD-304 and NITD-349 should undergo further development as a potential treatment for multidrug-resistant TB. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1126/scitranslmed.3007355 | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | MICROBIOLOGY | |
dc.description.doi | 10.1126/scitranslmed.3007355 | |
dc.description.sourcetitle | Science Translational Medicine | |
dc.description.volume | 5 | |
dc.description.issue | 214 | |
dc.description.page | - | |
dc.identifier.isiut | 000328057800005 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.